|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 330.20 CHF | +0.98% |
|
-1.40% | +0.61% |
| 10:57am | Berenberg Downgrades Qiagen Rating, Price Target Amid Rising Competition, Growth Concerns | MT |
| 06:40am | Roche's Gazyva/Gazyvaro Lands Priority Review From US FDA in Nephropathy | MT |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCHE HOLDING AG | Other Pharmaceuticals | +0.98% | -1.40% | +0.61% | +29.49% | -7.05% | 323B |
- Stock Market
- Stocks
- ROP Stock
- Charts Roche Holding AG
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















